The Global Orthokeratology Market, by Lens Type (Fluorosilicone Acrylate, Silicone Acrylate, Balafilcon, and Oprifocon A), by Application (Myopia, Hyperopia, Presbyopia, and Astigmatism), by Distribution Channel (Hospitals, Optometry Clinics, and Ophthalmology Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 37.6 million in 2017, and is projected to exhibit a CAGR of 7.0% over the forecast period (2018 - 2026).
Orthokeratology improves blurry vision without need of glasses, contact lenses, and corneal reshaping surgery such as photorefractive keratectomy (PRK) and laser-assisted in situ keratomileusis (LASIK). Moreover, it is cost-effective as compared to laser surgeries. Orthokeratology contact lenses are gaining significant traction with the method of slowing the progression of myopia in children. It is an alternative method to correct refractive errors using custom-designed rigid lenses, which modify the curvature of cornea for short duration. In recent years, the most common clinical application of ortho-k is for the reduction of myopia through corneal flattening. According to the Association of Optometrists, most orthokeratology lenses are suitable for myopes between -1.00 and -4.00 and Cylinder value (cyls) to 1.50 and 0.75.
Latest available product in market can correct high levels of myopia, potentially up to -10.00, and cyls to 2.50. In 2016, GP Specialists developed an advanced ortho-k lens iSee design shown to correct patients with high myopic powers. OrthoK in general is a safe option for myopia correction and retardation. However, the long-term success of the treatment depends on a combination of multiple factors including proper fitting of the lenses, rigorous compliance to lens use and care regimen, adherence to routine follow-ups, and timely and appropriate treatments to complications.
Browse 22 Market Data Tables and 26 Figures spread through 154 Pages and in-depth TOC on "Orthokeratology Market, by Lens Type (Fluorosilicone Acrylate, Silicone Acrylate, Balafilcon, and Oprifocon A), by Application (Myopia, Hyperopia, Presbyopia, Astigmatism), by Distribution Channel (Hospitals, Optometry Clinics and Ophthalmology Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"
To know the latest trends and insights related to orthokeratology market, click the link below:
https://www.coherentmarketinsights.com/market-insight/orthokeratology-market-2193
Manufacturers in orthokeratology market are majorly investing in development of progressive technologies and expert resources. For instance, in 2018, Euclid Systems Corporation introduced Emeraldä163 Ortho-K contact lens, featuring a hyper Dk lens material with outstanding oxygen transmissibility for optimal ocular health. Moreover, Paragon Vision Sciences’ Corneal Refractive Therapy (Paragon Z CRT) launched in 2002, and Bausch and Lomb’s Vision Shaping Treatment (VST) lenses launched in 2004, are the two major products available in the market so far.
Key Takeaways of the Orthokeratology Market:
- The global orthokeratology market is expected to expand at a CAGR of 7.0% during the forecast period (2018–2026), owing to increasing cases of myopia worldwide.
- Among region, the Asia Pacific is expected witness growth at highest rate, owing to increasing prevalence of myopia in East Asian countries including China, Japan, and South Korea among others.
- Major players operating in the global orthokeratology market include Autek China, Alpha Corporation, Bausch and Lomb Inc., Euclid Systems, E & E Optics, Essilor International S.A., GP Specialists, Paragon Vision Sciences, Procornea, and Taiwan Macro Vision Corporation.
